AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Xenon pauses new enrollment in depression drug trials over side-effect concerns - reuters.com

Xenon pauses new enrollment in depression drug trials over side-effect concerns - reuters.com

Xenon pauses new enrollment in depression drug trials over side-effect concerns reuters.com

September 17, 2026 at 10:46 PM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

No locations linked to this story

Tags

clinical research depression drug trials enrollment pause health healthcare pharmaceuticals side effects xenon

All Coverage

Xenon pauses new enrollment in depression drug trials over side-effect concerns - reuters.com
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxPYS1ySjRBMG5zZU5LMDhnQ1RtZV92ZElWUjhtZ2g1QlFXY1JLamRFejN5XzJhVWdUWjE5ODhjRFFuX1I3WEV0RVFlRG43dFl5c3hld1QzN3VWX25TOGppQVpaYjA5ODFjVmlmMDlUZFNLbklKTm1NY2lEVUlLM2VPbkFMR3Y5WXpaS2hZcmgtdUhyTmxFWG9SVmdwandGN0NiX3VnRU05dUZqUE8yRVc0d2JfeVZCNmhmWHRkYUJpNExtREx3U0hVY0Z3YjRIUkNVV2lxU3BIeE5wYVQ2NFdrQzR5ckkwZw?oc=5" target="_blank">Xenon pauses new enrollment in depression drug trials over side-effect concerns</a>&nbsp;&nbsp;<font color="#6f6f6f">reuters.com</font>

100%

Similar Stories

Related coverage based on topic and tags

Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - reuters.com

Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs reuters.com

September 21, 2026 at 05:02 AM

Merck's drug for diabetes-related eye disease meets trial goal - Reuters

Merck's drug for diabetes-related eye disease meets trial goal Reuters

September 24, 2026 at 02:52 PM

Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge - Reuters

Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge Reuters

September 22, 2026 at 08:10 PM

Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial - Reuters

Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial Reuters

September 22, 2026 at 11:25 AM

US FDA approves AbbVie's drug for Parkinson's disease - reuters.com

US FDA approves AbbVie's drug for Parkinson's disease reuters.com

September 25, 2026 at 10:57 PM

Yen steadies as intervention threat persists - reuters.com

Yen steadies as intervention threat persists reuters.com

September 21, 2026 at 01:34 AM